Liver size and radiation therapy for abdominal cancers
Part of Cancer clinical trials.
This study looks at how changes in liver size affect the planning and delivery of radiation therapy for cancers in the upper abdomen, such as pancreatic, bile duct, or liver cancer. It aims to improve treatment accuracy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of cancer in the upper abdomen (like pancreatic, bile duct, or liver cancer) that spread to the liver, adrenal glands, or nearby lymph nodes.
- Your doctor has planned a type of radiation therapy called SBRT for you.
- You have not had radiation therapy to your liver before.
- You can receive a special dye (contrast) given through an IV for your CT scan, unless allergies can be managed with medication.
- You are able to fast before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the liver changes in size after radiation therapy. It uses CT scans taken before and after treatment to measure these changes, which could help doctors better understand and manage side effects.
This study compares a standard radiation dose plan versus a plan that adjusts the dose based on how the tumor responds to radiation-related measurements. It aims to improve how well stereotactic body radiation therapy (SBRT) treats liver cancer while keeping side effects manageable.
This study uses a form of targeted radiation placed inside/near the liver to treat liver tumors that can’t be surgically removed. It’s meant to shrink or control tumors, especially when they sit near blood vessels or other sensitive organs.
This trial studies giving targeted high-dose radiation (SBRT) to liver metastases from colorectal cancer after initial treatment, with the goal of improving long-term control or cure. It may help people who have a limited number of liver spots that doctors think can be treated safely and effectively.
This trial tests combining radiation therapy (radioembolization) with surgery to remove part of the liver for people with a single large liver tumor (over 8 cm) that hasn't spread. The goal is to see if this approach can treat the tumor effectively.
This trial studies how well the liver works after stereotactic body radiation therapy (SBRT) for cancer that spread to the liver. If you had this specific type of radiation in three large doses, you may help researchers learn more about liver recovery.
Hear when a new Upper Abdominal Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.